Recent Finacing
Recent Raise
Acton Pharmaceuticals licenses and commercializes AEROSPAN, an FDA-approved inhaled corticosteroid for asthma, handling development, marketing, and U.S. sales with targeted promotion to asthma specialists.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor